BMRN
BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc. is a biotechnology company focused on rare genetic diseases, with its strongest political signal being a $2.96M annual physician payment program and a disclosed stock holding by a former President.
Govt Dependence
5/100
Regulatory Density
95/100
Lobbying Intensity
0/100
Political Signal
NEUTRAL
BusinessWhat BMRN does
BioMarin develops and commercializes therapies for rare genetic diseases. Its revenue is derived from the sale of enzyme replacement and other biologic treatments. The company operates in a highly regulated pharmaceutical market.
6 months past · 3 months futureBMRN activity timeline
Congress
buy
sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened
+ added
− trimmed
closed
holds
Bills
past action (this ticker)
upcoming markup (sector)
★ carveout (this ticker)
109 trading days ·
0 congressional trades shown
·
0 insider buys
·
4 13F filings
·
0 past bill actions
·
16 upcoming markups
Executive Branch ConflictsBMRN held by Trump-administration officials
1 cabinet/senior official reported BMRN positions in OGE Form 278 disclosures across 1 filings.
Lifetime Government AwardsBMRN federal contracts by year
$0
total awarded · 2021–2021
2
contracts on file
2021
peak year ($0)
Top contracts by award amount
$0K
Department of Veterans Affairs
2021-07-29
PALYNZIQ
$0K
Department of Veterans Affairs
2021-10-13
PHARMACY EMERGENCY FOR PALYNIQ FOR OKC
1 years · 2 contracts
Smart Money · 13F HoldingsHedge funds holding BMRN
$6.17B
Total BMRN held by tracked 13F funds
40
Funds with BMRN positions
+40
Funds opened this quarter
Viking Global Investors
$763M
opened
2025-03-31
Viking Global Investors
$691M
opened
2024-12-31
Viking Global Investors
$686M
opened
2024-09-30
Viking Global Investors
$676M
opened
2025-06-30
Viking Global Investors
$582M
opened
2024-06-30
Viking Global Investors
$560M
opened
2024-03-31
Viking Global Investors
$451M
opened
2025-09-30
Viking Global Investors
$359M
opened
2025-12-31
32 more 13F positions tracked · quarterly delta charts available in member dashboard
Congressional TradesWho in Congress is trading BMRN
2023-03-06
Daniel S. Goldman
Sale
$1,001 - $15,000
2023-03-06
Daniel S. Goldman
sale
$1,001 - $15,000
2023-03-14
Ro Khanna
Sale
$1,001 - $15,000
2023-03-14
Ro Khanna
sale
$1,001 - $15,000
2022-05-10
Ro Khanna
sale
$1,001 - $15,000
2022-05-10
Ro Khanna
Sale
$1,001 - $15,000
2021-10-18
Josh Gottheimer
sale
$1,001 - $15,000
2021-10-18
Josh Gottheimer
Sale
$1,001 - $15,000
2020-12-30
Gilbert Ray Cisneros
purchase
$15,001 - $50,000
2020-12-30
Gilbert Ray Cisneros
Purchase
$15,001 - $50,000
2020-10-16
Josh Gottheimer
purchase
$1,001 - $15,000
2020-10-16
Josh Gottheimer
Purchase
$1,001 - $15,000
30+ trades on file · most recent 2023-04-17
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Bills Affecting BMRNLive legislation impacting this stock
S.827 · 119th
Supporting Rural Veterans Access to Healthcare Services Act
HR.1860 · 119th
Women Veterans Cancer Care Coordination Act
HR.2068 · 119th
Veterans Patient Advocacy Act
HR.2020 · 119th
New Mexico Rural Veteran Health Care Access Act
S.999 · 119th
Public Health Improvement Act
HR.2045 · 119th
Medicare Dental, Vision, and Hearing Benefit Act of 2025
HR.2062 · 119th
To amend the Internal Revenue Code of 1986 to treat membership in a health care sharing ministry as a medical expense, and for oth
HR.2048 · 119th
Metastatic Breast Cancer Access to Care Act
HR.2085 · 119th
Mental Health Research Accelerator Act of 2025
SJRES.36 · 119th
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted b
Political ProfileWhere BMRN sits in Washington
[object Object]
STRUCTURAL: High regulatory density from healthcare sector and physician payment program ($2.96M in 2024). EVIDENTIARY: Single executive branch holding (Trump, $1K-$15K bucket) and zero federal contract dollars, lobbying spend, or congressional trades. Net: High structural oversight offset by minimal direct political engagement.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
Heightened scrutiny of physician payment programs under transparency lawsCMS/Open Payments"`get_political_influence.doctor_payments` shows $2.96M in payments to physicians in 2024."
Regulatory opportunities
-
Potential for federal procurement of rare disease therapiesDepartment of Veterans Affairs"`get_government_precedent.federal_contracts_summary` lists the VA as a contracting agency, though obligation is $0."
Member intelligence layer
Live signals + predictions for BMRN — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades BMRN
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord
Frequently AskedAbout BMRN & political exposure
Does BioMarin Pharmaceutical Inc. (BMRN) hold federal contracts?
Yes. BioMarin Pharmaceutical Inc. has 2 federal contract awards totaling $0, primarily from agencies including Department of Veterans Affairs. See full contract list and amounts on this page.
Which Trump cabinet officials own BMRN stock?
1 Trump cabinet members or senior White House staff have disclosed holdings in BMRN on their OGE 278 financial disclosures, including Donald J. Trump. See the Cabinet Conflicts panel for details.
Has Congress traded BMRN stock?
58 congressional trades by 9 unique members of Congress, most recently on 2023-03-14. See the Congressional Trading panel for politician-by-politician breakdown.
What is BMRN political risk profile?
Government dependence: 5/100. Lobbying intensity: 0/100. Political signal: neutral. Donor party split: R 0% / D 0%.
How does GovGreed track BMRN political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. BMRN data is updated daily from these official federal sources.